GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: GSK-2398852 | GSK2398852
Compound class:
Antibody
Comment: Dezamizumab (GSK2398852) is an anti-human serum amyloid P component (anti-SAP) monoclonal antibody, that was developed by GlaxoSmithKline as a potential therapy for the rare disease amyloidosis.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10364 | dezamizumab |
Synonyms ![]() |
| GSK-2398852 | GSK2398852 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 652 |
| Other databases | |
| GtoPdb PubChem SID | 249565935 |
| Search PubMed clinical trials | dezamizumab |
| Search PubMed titles | dezamizumab |
| Search PubMed titles/abstracts | dezamizumab |